THAMES VENTURES VCT 1 PLC
LEI: 213800R88MRC4Y3OIW86
HALF-YEARLY REPORT FOR THE
SIX MONTHS ENDED 30 SEPTEMBER 2023
Financial Summary
| 30 Sep | 31 Mar | 30 Sep | Nov | ||
| 2023 | 2023 | 2022 | 2013 | ||
| pence | pence | pence | pence | ||
| Unaudited | Audited | Unaudited | Unaudited | ||
| Net Asset Value per share (“NAV”) | 48.5 | 51.8 | 58.8 | 100.4 | |
| Cumulative dividends paid since Nov 2013 | 45.5 | 44.5 | 43.0 | - | |
| Total Return (NAV plus cumulative dividends paid per share) | 94.0 | 96.3 | 101.8 | 100.4 | |
Chairman’s Statement
I present the Company’s unaudited Half-Yearly Financial Report for the six months ended 30 September 2023.
Following an eventful year ended 31 March 2023 for the Company, with the main Investment Adviser changing from Downing LLP to Foresight Group LLP, the six-month period ended 30 September 2023 has been more settled from a management perspective. However, performance has been disappointing, with the UK investment environment continuing to remain challenging.
Net asset value and results
As at 30 September 2023, the Company’s NAV stood at 48.5p, a decrease of 2.3p (or 4.4%) compared to the 31 March 2023 year-end position, after adding back the 1.0p dividend paid during the period.
The loss attributable to equity shareholders for the period was £4.4 million, comprising a revenue gain of £0.2 million and a capital loss of £4.6 million.
Investment activity and performance
Over the last six months the Company has made new and follow-on investments totalling £2.4 million, as well as receiving proceeds of £3.3 million from exit events across the portfolio.
At the period end, the Company held a portfolio of 63 active investments, with 54% in unquoted growth (by value), 26% held in quoted growth and 20% in unquoted yield focused investments. A total of 31 investments are held in the quoted growth category which are either quoted on AIM, the Main Market or the AQSE Growth Market and have a value of £16.9 million. This includes one investment in new company, DXS International Plc. The 32 unquoted investments have a value of £48.9 million.
The reduction in value of the Company’s investments over the period was driven by a large reduction (£4.1 million) in the valuation of Cornelis Networks Inc., with the Company’s position being heavily diluted as a result of being unable to participate in the most recent funding round, as the portfolio company no longer meets the gross assets test in order to be VCT qualifying. Limitless Limited also experienced a decrease in valuation of £625,000, due to a co-investor remaining on the UK sanctions list. Furthermore, the valuation of the quoted portfolio fell by £1.9 million during the period, following the trend of the FTSE AIM All Share market.
Offsetting the valuation decreases above, there were some positive valuation movements seen from Carbice Limited, Cambridge Touch Technologies and FundingXchange Limited. Further details can be found in the Investment Adviser’s Report on pages 4 to 6.
Dividends
The Company has a stated policy of seeking to pay dividends equivalent to at least 4% of NAV each year. The Board has declared an interim dividend of 1.0p (equivalent to 2.1% of NAV at 30 September 2023) which will be paid on 2 February 2024 to Shareholders on the register as at 29 December 2023.
The above interim dividend will take the total dividends paid since the merger in November 2013 to 46.5p per share.
Running costs
Shareholders are reminded that the Company benefits from a running cost cap provided by the Investment Adviser, whereby any costs above 2.6% of net assets per annum are met by the Adviser by way of a reduction in their fees.
Special Administration of the Company’s Custodian of Quoted Assets
Since September 2020, the Company has used IBP Markets Limited ("IBP") as custodian for its quoted investments. Appointing a custodian is a requirement of the FCA, and IBP is an FCA authorised and regulated wholesale broker, providing custody services and access to equity and fixed income securities for non-retail clients (which includes the Company). On 13 October 2023, the FCA published a supervisory notice under section 55L(3)(a) of the Financial Services and Markets Act 2000, imposing certain restrictions on IBP. On the same date, IBP applied to the High Court and special administrators were appointed. The special administrators have yet to publish an estimated outcome statement and therefore the full impact is currently unknown. The Investment Adviser is actively collaborating with the special administrators to reach a resolution and will communicate with Shareholders when further information becomes available. Whilst this is being resolved, the Company is unable to trade any of its AIM and fully listed portfolio on the quoted market.
The Investment Adviser is in regular dialogue with the special administrators. The outcome remains subject to change particularly as additional claims may be made on custody assets and client money and there remains a risk to the positions. However, considering the information made available to the Company at the date of this report, there is currently little indication that there will be a materially adverse impact to Shareholders with respect to the custody assets. The position with respect to client money remains to be determined, but total cash at IBP represented less than 1.5% of NAV as at 30 September.
Fundraising
With the uncertainty brought about by the special administration of the custodian of the Company’s quoted stocks, we have not been in a position to launch a fundraise so far this year. Once clarity is achieved on the IBP situation, the Board will be able to consider options for fundraising and will communicate this with Shareholders.
Share buybacks
The Company usually operates a policy of buying back its own shares that become available in the market, subject to regulatory and liquidity factors. The Board review these on a regular basis and will make appropriate adjustments as it sees fit.
Historically, we have been able to rely on the fact that we could liquidate part of our quoted portfolio if there was ever a shortage of cash. Unfortunately, given the IBP situation noted above, we would not currently be able to do this if required in the short term. Although our cash position remains reasonably healthy at the moment, the Board have reviewed the investment pipeline and cash flow forecast for the next 12 months and deem it prudent to be cautious with regard to the Company’s uninvested funds and not undertake any buybacks. The Board will review this decision at the end of February 2024 when the IBP situation is clearer.
Sunset clause
A “sunset clause” applies to the current approved scheme for EIS and VCT tax reliefs. This clause provides that income tax relief will expire on subscriptions made for VCT shares on or after 6 April 2025, unless the legislation is amended to make the scheme permanent, or the “sunset clause” is extended.
The UK Chancellor confirmed in the autumn statement that the government remains committed to ensuring early-stage, innovative companies have access to the investment they need to grow and develop. As a result it was announced on 22 November 2023 that the government will legislate to extend the Enterprise Investment Scheme (‘EIS’) and Venture Capital Trusts (‘VCT’) to 2035.
Directorate
It was earlier communicated that within this period, Stuart Goldsmith, the last remaining founding Director of the Company, would be stepping down from the Board. My fellow Directors and I express our gratitude for his dedicated work throughout the years. On December 12, 2022, as part of a planned succession, Atul Devani officially joined the Board, contributing his VCT experience and expertise in the technology sector, enriching the Board's capabilities going forward.
Change of Company Secretary and Registered Office
I am pleased to announce that Foresight Group LLP was appointed as Company Secretary effective from 1 September 2023, succeeding Grant Whitehouse. I would like to take this opportunity to thank Grant for his many years of dedication and service to the Company.
Outlook
Businesses continue to face multiple challenges in the UK and internationally. The investment team will continue to monitor the existing portfolio companies closely to ensure management address the macroeconomic challenges appropriately and have the support that they need to do so. The Board hopes to see the ventures investment team continue to leverage the full benefits of the regional office network and other resources of Foresight Group.
Chris Kay
Chairman
21 December 2023
Investment Adviser’s Report
We present our Investment Adviser’s Report for the six-month period to 30 September 2023.
Unquoted Portfolio
Investment focus
In line with the current VCT regulations, the Company focus has for some years now been on young unquoted growth businesses. This focus will continue and other areas of Thames Ventures VCT 1’s portfolio are expected to continue to reduce in size as suitable exit opportunities arise and proceeds are reinvested in the core area.
Investment activity
During the period, the Company invested a total of £1.9 million as further funding into two existing unquoted portfolio companies.
There were no investments made into new unquoted companies during the period, however, shortly after the period-end, £1.4 million was invested in a new company, Inoviv Limited. Inoviv has a long-term data play in drug discovery and trials, having developed novel precision biomarker technology which helps pharmaceutical customers run drug trials more efficiently. This investment will enable Inoviv to further accelerate their commercial plans, including facilitating the development of tests across more diseases.
The above excludes activity in the quoted portfolio, which is detailed in isolation on page 5 of this report.
The two follow-on investments are summarised as follows:
A further £1.75 million was invested into existing portfolio company, Cambridge Touch Technologies Limited, a company developing pressure sensitive multi touch technology.
A total of £150,000 was invested into Cambridge Respiratory Innovations Limited (now trading as Tidal Sense) who have developed a patent‐protected ultrahigh sensitivity handheld capnometer to provide actionable insights at the point of care for the diagnosis, monitoring and management of cardiorespiratory conditions.
There were 11 full exits of unquoted investments in the period, as summarised below:
Imagen Limited, a Software as a Service (“SaaS”) video management platform which holds both current and archive footage for major sporting organisations and news outlets. The company was sold for initial cash consideration of £1.7 million at a gain over cost of £0.7 million. There is also £0.2 million deferred consideration, taking total proceeds to £1.9 million and a total gain over cost of £0.9 million. DiA Imaging Analysis, a leading provider of advanced Artificial Intelligence based solutions for ultrasound analysis, was also sold in the period for initial proceeds of £0.2m versus cost invested of £0.2m. There is also a deferred element of consideration meaning a gain over cost will be realised on this exit.
There were further proceeds of £0.3 million received in relation to the winding up of two investments in the unquoted yield-focused portfolio, Downing Pub EIS ONE Limited and Pearce & Saunders Limited. No further proceeds are anticipated on these investments.
Portfolio valuation
Excluding the portfolio of quoted investments, there were net valuation losses of £2.5 million over the period, which included £0.1 million of unrealised foreign exchange gains.
Eleven companies in the portfolio recorded a combined valuation gain of £3.7 million in the period. However, this was offset by a number of companies reporting combined valuation losses totalling £6.2 million. This is driven by the ongoing challenges for businesses operating in the UK and associated restriction on access to capital. The £3.7 million of uplift in valuation over the period is driven by the following investments.
Carbice Limited (£1.6 million), the developer of a suite of products based on its carbon material called Carbice Carbon which is primarily used as thermal management solutions to enable greater thermal conductivity, has continued to progress well during the period, with recurring revenues continuing to grow and continued progress on fundraising. This movement includes the impact of FX as this is a USD-denoted investment.
Cambridge Touch Technologies Limited (£862,000), a company developing pressure sensitive multi touch technology. The value of this investment was uplifted to reflect the valuation of the round which completed during the period.
FundingXchange Limited (£718,000), an SME funding platform and B2B technology provider which enables online lending. After a challenging twelve months, this company has negotiated additional funding to deliver its growth plan. The valuation of this investment has therefore been uplifted to reflect this.
Offsetting these valuation uplifts, are a number of valuation decreases across the unquoted portfolio.
Cornelis Networks, Inc. (£4.1 million) is a technology provider delivering purpose-built high-performance fabrics for High Performance Computing, Analytics and Artificial Intelligence to leading commercial, scientific, academic, and government organizations. The valuation was amended to reflect a funding round which closed in the period in which Thames Ventures VCT 1 Plc was unable to participate due to the company not meeting the gross assets test to be VCT-qualifying. Not participating led to a significant dilution of the Company’s stake which has been reflected in the movement in valuation. This movement includes the impact of FX as this is a USD-denoted investment.
Limitless Limited (£625,000), the developer of a crowdsourced customer service platform, was subject to a valuation reduction as a result of one of the co-investors being on the UK Sanctions List giving rise to a funding risk.
CommerceIQ Inc. (£394,000), the pioneer in helping brands win on retail ecommerce channels. Their unified platform applies machine learning and automation across marketing, supply chain, and sales operations to help brands gain market share profitably. This valuation movement is simply a reflection of current market conditions. The company continues to perform well growing revenues during the period and supported by a very strong balance sheet. This movement includes the impact of FX as this is a USD-denoted investment.
Data Centre Response Limited (£344,000), a provider of uninterruptable power supply systems. A discount has been applied to the EBITDA multiple approach to reflect the challenging market conditions which has led to an unrealised fair value loss on this investment.
There are a number of smaller valuation movements which partially offset one another for the half-year period, ultimately resulting in an additional net decrease in value of £238,000.
Quoted Portfolio
Investment focus
The Company continues to hold a portfolio of quoted investments, most of which are quoted on the AIM market. The team at Downing LLP continue to provide management services in respect of these investments under a subcontract agreement with Foresight.
Investment activity
At 30 September 2023, the quoted portfolio comprised 31 investments with a value of £16.9 million. There was only one material transaction in the period – the part sale of Tracsis plc realising a gain £548,000. The decision to take profits in this holding was to reduce the large exposure to the Company after the share price had performed well. Tracsis remains one of the larger positions in the portfolio, reflecting our confidence in this niche transport software business.
There were two investments made into quoted assets during the period: new investment DXS International Plc (£300,000) and existing investment Deepmatter Group Plc (£159,000).
Portfolio valuation
The quoted portfolio continued to be volatile in the period, following the trend of the FTSE AIM All Share market which was down 11.6%, which drove a £1.9 million fall in net valuation in the period.
Ten companies in the portfolio recorded a combined valuation gain of £0.8 million, however this was offset by a number of companies reporting combined valuation losses totalling £2.7 million. Driving the gains in the period were uplifts in Anpario Plc (£402,000) and Craneware Plc (£243,000) however material unrealised losses include Tracsis Plc (£547,000), Genincode Plc (£292,000), Libertine Holdings Plc (£254,000), Inland Homes Plc (£210,000) and Impact Healthcare REIT Plc (£210,000). The remaining portfolio recorded a total unrealised loss of £1.0 million. Whilst the companies continued to trade resiliently, this was not necessarily reflected in share prices. Since the period end, share prices have begun to recover into the December pre-Christmas trading period.
Although our view continues to be that the coming months are likely to remain challenging from a macroeconomic perspective, there is certainly renewed interest in UK smaller companies with the FTSE AIM All Share up over 9% since the beginning of November. The Investment Adviser is pleased to note that at the date of this report, the quoted portfolio had recovered by £0.7 million since the period end, representing a 4.4% uplift. We reiterate that the quoted portfolio contains good quality companies, with plenty of scope for self-help, strong balance sheets, and significant prospects for growth over the long-term which we hope will translate into an improved longer term share price performance.
Outlook
The six months to 30 September 2023 has continued to see increasingly challenging market conditions, with inflation and global interest rates still high, which has had an inevitable impact on the portfolio.
Further to this, there have been a number of events impacting the valuation of unquoted investments which have been unavoidable, as detailed above, and the volatility of the quoted portfolio remains in line with FTSE AIM All Share market trends.
Despite this, we continue to see improved performance from certain portfolio companies and anticipate this will continue. Further to this, the economic situation has recently seen its first glimpse of hope with the UK’s annual inflation rate falling sharply in October, its lowest level for two years. This being said, we are cognisant that the market has been, and will continue to be, tough for many of these companies. The portfolio companies that survive this economic turbulence may be better placed than beforehand, due to tighter cost and cash management.
We continue to expand our team to enable us to take full advantage of the opportunities we are seeing, whilst continuing to support the existing portfolio companies.
Thames Ventures Team
Foresight Group LLP
21 December 2023
Unaudited Income Statement
For the six months ended 30 September 2023
| Six months ended 30 September 2023 (Unaudited) | Six months ended 30 September 2022 (Unaudited) | Year ended 31 March 2023 (Audited) | ||||||
| Revenue | Capital | Total | Revenue | Capital | Total | Total | ||
| Note | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
| Income | 1,065 | - | 1,065 | 2,710 | - | 2,710 | 3,031 | |
| Losses on investments | 10 | - | (4,175) | (4,175) | - | (3,728) | (3,728) | (12,351) |
| 1,065 | (4,175) | (3,110) | 2,710 | (3,728) | (1,018) | (9,320) | ||
| Investment management fees | (449) | (449) | (898) | (275) | (275) | (550) | (1,598) | |
| Other expenses | (376) | - | (376) | (388) | - | (388) | (812) | |
| Return/(loss) on ordinary activities before tax | 240 | (4,624) | (4,384) | 2,047 | (4,003) | (1,956) | (11,730) | |
| Tax on total comprehensive income and ordinary activities | (24) | 24 | - | (78) | 78 | - | - | |
| Return/(loss) attributable to equity shareholders | 5 | 216 | (4,600) | (4,384) | 1,969 | (3,925) | (1,956) | (11,730) |
| Basic and diluted return per share | 0.1p | (2.5)p | (2.4)p | 1.1p | (2.2)p | (1.1)p | (6.5)p | |
The total column within the Income Statement represents the Statement of Total Comprehensive Income of the Company prepared in accordance with Financial Reporting Standards (“FRS102”). There are no other items of comprehensive income. The supplementary revenue and capital return columns are prepared in accordance with the Statement of Recommended Practice issued in November 2014 and updated in July 2022 by the Association of Investment Companies (“AIC SORP”).
Unaudited Balance Sheet
as at 30 September 2023
Company number: 03150868
| | | 30 Sep 2023 | 30 Sep 2022 | 31 Mar 2023 | ||
| £’000 | £’000 | £’000 | ||||
| Note | (Unaudited) | (Unaudited) | (Audited) | |||
| Fixed assets | ||||||
| Investments | 10 | 65,871 | 81,130 | 71,227 | ||
| Current assets | ||||||
| Debtors | 7,393 | 5,896 | 6,828 | |||
| Cash at bank and in hand | 13,580 | 20,051 | 15,282 | |||
| 20,973 | 25,947 | 22,110 | ||||
| Creditors: amounts falling due within one year | (1,077) | (1,298) | (1,354) | |||
| Net current assets | 19,896 | 24,649 | 20,756 | |||
| Net assets | 85,767 | 105,779 | 91,983 | |||
| Capital and reserves | ||||||
| Called up share capital | 8 | 1,770 | 1,799 | 1,774 | ||
| Capital redemption reserve | 9 | 71 | 1,711 | 32 | ||
| Share premium account | 9 | 2,252 | 81,236 | 428 | ||
| Funds held in respect of shares not yet allotted | 9 | - | 16 | - | ||
| Special reserve | 9 | 85,122 | 15,873 | 88,813 | ||
| Capital reserve realised | 9 | (5,627) | - | - | ||
| Revaluation reserve | 9 | 3,619 | 6,024 | 2,592 | ||
| Revenue reserve | 9 | (1,440) | (880) | (1,656) | ||
| Equity shareholders’ funds | 85,767 | 105,779 | 91,983 | |||
| Basic and diluted net asset value per share | 7 | 48.5p | 58.8p | 51.8p | ||
Statement of Changes in Equity
For the six months ended 30 September 2023
| Called up share capital | Capital redemption reserve | Share premium account | Special reserve | Capital reserve realised | Revaluation reserve | Revenue reserve | Total | |
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
| For the six months ended 30 September 2023 | ||||||||
| At 1 Apr 2023 | 1,774 | 32 | 428 | 88,813 | - | 2,592 | (1,656) | 91,983 |
| Total comprehensive income | - | - | - | - | (5,627) | 1,027 | 216 | (4,384) |
| Transactions with owners | ||||||||
| Dividend paid | - | - | - | (1,779) | - | - | - | (1,779) |
| Issue of new shares | 29 | - | 1,556 | - | - | - | - | 1,585 |
| Share issue costs | - | - | (7) | - | - | - | - | (7) |
| Shares issued under the dividend reinvestment scheme | 6 | - | 275 | - | - | - | - | 281 |
| Purchase of own shares | (39) | 39 | - | (1,912) | - | - | - | (1,912) |
| At 30 Sept 2023 | 1,770 | 71 | 2,252 | 85,122 | (5,627) | 3,619 | (1,440) | 85,767 |
Statement of Changes in Equity
For the year ended 31 March 2023
| Called up share capital | Capital redemption reserve | Share premium account | Funds held in respect of shares not yet allotted | Special reserve | Capital reserve realised | Revaluation reserve | Revenue reserve | Total | |
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
| For the year ended 31 March 2023 | |||||||||
| At 1 April 2022 | 1,776 | 1,697 | 79,035 | 78 | 16,328 | - | 11,303 | (744) | 109,473 |
| Total comprehensive income | - | - | - | - | - | (1,204) | (11,718) | 1,192 | (11,730) |
| Realisation of revaluations from previous years* | - | - | - | - | - | 2,438 | (2,438) | - | - |
| Realisation of impaired valuations | - | - | - | - | - | (5,445) | 5,445 | - | - |
| Transfer between reserves* | - | (1,710) | (81,236) | - | 74,984 | 7,962 | - | - | - |
| Transactions with owners | |||||||||
| Dividends paid | - | - | - | - | - | (3,751) | - | (2,104) | (5,855) |
| Utilised in share issue | - | - | - | (78) | - | - | - | (78) | |
| Issue of new shares | 43 | - | 2,680 | - | - | - | - | - | 2,723 |
| Share issue costs | - | - | (51) | - | - | - | - | - | (51) |
| Purchase of own shares | (45) | 45 | - | - | (2,499) | - | - | - | (2,499) |
| At 31 March 2023 | 1,774 | 32 | 428 | - | 88,813 | - | 2,592 | (1,656) | 91,983 |
* A transfer of £nil representing previously recognised unrealised gains on disposal of investments during the period ended 30 September 2023 (year ended 31 March 2023: £2.4m) has been made from the revaluation reserve to the capital reserve -realised.
A transfer of £nil representing realised gains on disposal of investments, less the excess of capital expenses over capital income and capital dividends in the period (year ended 31 March 2023: losses £8.0m) has been made from the capital reserve - realised to the special reserve.
Unaudited Cash Flow Statement
For the six months ended 30 September 2023
| Six months ended 30 Sep 2023 | Six months ended 30 Sep 2022 | Year ended 31 Mar 2023 | ||||
| (Unaudited) | (Unaudited) | (Audited) | ||||
| £’000 | £’000 | £’000 | ||||
| Cash flow from operating activities | ||||||
| Loss on ordinary activities before taxation | (4,384) | (1,956) | (11,730) | |||
| Loss on investments | 4,175 | 3,728 | 12,351 | |||
| Increase/(decrease) in creditors | 82 | 635 | (60) | |||
| Increase in debtors | (891) | (2,596) | (3,529) | |||
| Cash from operations | ||||||
| Corporation tax paid | - | - | - | |||
| Net cash outflow from operating activities | (1,018) | (189) | (2,968) | |||
| Cash flow from investing activities | ||||||
| Purchase of investments | (2,209) | (5,673) | (11,758) | |||
| Proceeds from disposal of investments | 3,295 | 6,769 | 14,134 | |||
| Proceeds from deferred consideration | 419 | - | - | |||
| Net cash inflow from investing activities | 1,505 | 1,096 | 2,376 | |||
| Cash flows from financing activities | ||||||
| Proceeds from share issue | 1,586 | 2,289 | 1,781 | |||
| Funds held in respect of shares not yet allotted | - | 0 | (63) | (78) | ||
| Share issue costs | (7) | (51) | (51) | |||
| Purchase of own shares | (2,270) | (729) | (1,723) | |||
| Equity dividends paid | (1,498) | (3,158) | (4,911) | |||
| Net cash outflow from financing activities | (2,189) | (1,712) | (4,982) | |||
| Decrease in cash | (1,702) | (805) | (5,574) | |||
| Net movement in cash | ||||||
| Beginning of period | 15,282 | 20,856 | 20,856 | |||
| Net cash outflow | (1,702) | (805) | (5,574) | |||
| End of period | 13,580 | 20,051 | 15,282 | |||
Summary of Investment Portfolio
as at 30 September 2023
| Cost | Valuation | Additions / (disposals) | Valuation movement in period† | % of portfolio by value | ||
| £’000 | £’000 | £’000 | £’000 | |||
| Top twenty venture capital investments (by value) | ||||||
| Tracsis Plc* | 1,297 | 5,541 | (694) | (547) | 7.0% | |
| Doneloans Limited | 3,631 | 4,146 | - | (10) | 5.2% | |
| Cambridge Touch Technologies Limited | 2,709 | 4,078 | 1,750 | 862 | 5.1% | |
| Downing Strategic Micro-cap Investment Trust Plc** | 5,699 | 3,559 | - | (181) | 4.5% | |
| Carbice Corporation Inc | 3,020 | 3,532 | - | 1,649 | 4.4% | |
| Ayar Labs Inc | 1,280 | 3,173 | - | 46 | 4.0% | |
| Baron House Developments LLP | 2,695 | 2,961 | - | (57) | 3.7% | |
| Hackajob Limited | 2,284 | 2,568 | - | (18) | 3.2% | |
| Virtual Class Limited | 1,164 | 2,183 | - | (112) | 2.8% | |
| Cadbury House Holdings Ltd | 3,082 | 2,162 | - | - | 2.7% | |
| Data Centre Response Limited | 557 | 2,022 | - | (344) | 2.5% | |
| Maestro Media Limited | 1,320 | 1,868 | - | - | 2.4% | |
| Trinny London Limited | 443 | 1,813 | - | (76) | 2.3% | |
| Rated People Limited | 1,582 | 1,743 | - | (78) | 2.2% | |
| Anpario Plc* | 1,448 | 1,608 | - | 402 | 2.1% | |
| Parsable Inc | 1,532 | 1,529 | - | 23 | 1.9% | |
| Vivacity Labs Limited | 1,289 | 1,443 | - | - | 1.8% | |
| Bulbshare Limited | 749 | 1,349 | - | 67 | 1.7% | |
| CommerceIQ Inc | 1,749 | 1,337 | - | (394) | 1.7% | |
| FundingXchange Limited | 1,335 | 1,279 | - | 718 | 1.6% | |
| 38,865 | 49,894 | 1,056 | 1,950 | 62.8% | ||
| Other venture capital investments | 38,772 | 15,977 | (1,992) | (6,370) | 20.1% | |
| Total investments | 77,637 | 65,871 | (936) | (4,420) | 82.9% | |
| Cash at bank and in hand | 13,580 | 17.1% | ||||
| Total investments and cash | 79,451 | 100.0% | ||||
All venture capital investments are unquoted unless otherwise stated.
* Quoted on AIM
** Listed and traded on the Main Market of the London Stock Exchange
† The valuation movement in the period includes unrealised foreign exchange gains of £110,000.
Summary of Investment Movements
For the six months ended 30 September 2023
Additions
| £’000 | |
| Quoted investments | |
| DXS International Plc | 300 |
| Deepmatter Group Plc | 159 |
| 459 | |
| Unquoted investments | |
| Cambridge Touch Technologies Limited | 1,750 |
| Tidalsense Limited | 150 |
| 1,900 | |
| Total additions | 2,359 |
Disposals
| | Cost | Value at 31/03/23 | Proceeds | Valuation movement in period | Realised gain/(loss) |
| £’000 | £’000 | £’000 | £’000 | £’000 | |
| Quoted growth investments | |||||
| Tracsis Plc | 146 | 686 | 694 | 8 | 548 |
| Let's Explore Group Plc | 325 | 276 | 375 | 99 | 50 |
| Genincode Plc | 26 | 23 | 18 | (5) | (8) |
| 497 | 985 | 1,087 | 102 | 590 | |
| Unquoted yield focused investments | |||||
| Pearce & Saunders Ltd | 1,122 | - | 172 | 172 | (950) |
| Downing Pub EIS ONE Limited | 68 | 94 | 87 | (7) | 19 |
| Pearce & Saunders Devco Ltd | 84 | 70 | - | (70) | (84) |
| Quadrate Spa Ltd | 372 | - | - | - | (372) |
| Top Ten Holdings Plc | 399 | - | - | - | (399) |
| Quadrate Catering Ltd | 1,500 | - | - | - | (1,500) |
| Yamuna Renewables Limited | 2,500 | - | - | - | (2,500) |
| 6,045 | 164 | 259 | 95 | (5,786) | |
| Unquoted growth investments | |||||
| Imagen Limited | 1,000 | 1,703 | 1,746 | 43 | 746 |
| DIA Imaging Analysis Limited | 207 | 282 | 196 | (86) | (11) |
| Ludorum Plc | 177 | - | 7 | 7 | (170) |
| Live Better With Limited | 990 | - | - | - | (990) |
| 2,374 | 1,985 | 1,949 | (36) | (425) | |
| 8,916 | 3,134 | 3,295 | 161 | (5,621) | |
Notes to the Unaudited Financial Statements
For the six months ended 30 September 2023
- General information
Thames Ventures VCT 1 plc (“the Company”) is a Venture Capital Trust established under the legislation introduced in the Finance Act 1995 and is domiciled in the United Kingdom and incorporated in England and Wales.
- Basis of accounting
The unaudited half-yearly financial results cover the six months to 30 September 2023 and have been prepared in accordance with the accounting policies set out in the statutory accounts for the year ended 31 March 2023, which were prepared in accordance with the Financial Reporting Standard 102 (“FRS102”) and in accordance with the Statement of Recommended Practice “Financial Statements of Investment Trust Companies” issued in November 2014 and updated in July 2022 (“SORP”).
- The Company has only one class of business and derives its income from investments made in shares, securities and bank deposits.
- The comparative figures were in respect of the six months ended 30 September 2022 and the year ended 31 March 2023 respectively.
- Return per share
| Weighted average number of shares in issue | Revenue return | Capital loss | |||
| £’000 | £’000 | ||||
| Six months ended 30 September 2023 | 179,310,912 | 216 | (4,600) | ||
| Six months ended 30 September 2022 | 180,153,252 | 1,969 | (3,925) | ||
| Year ended 31 March 2023 | 179,972,333 | 1,192 | (12,922) | ||
- Dividends paid in the period
| Six months ended 30 September 2023 | Year ended 31 March 2023 | |||||
| Revenue | Capital | Total | Total | |||
| Date paid | £’000 | £’000 | £’000 | £’000 | ||
| 2023 Final | Sep 2023: 1.0p | - | 1,779 | 1,779 | - | |
| 2023 Interim | Jan 2023: 1.5p | - | - | - | 2,699 | |
| 2022 Final | Aug 2022: 1.75p | - | - | - | 3,156 | |
| - | 1,779 | 1,779 | 5,855 | |||
- Basic and diluted net asset value per share
| Shares in issue | Net assets | NAV per share | |||
| No. | £’000 | Pence | |||
| 30 September 2023 | 176,968,887 | 85,767 | 48.5 | ||
| 30 September 2022 | 179,899,225 | 105,779 | 58.8 | ||
| 31 March 2023 | 177,441,775 | 91,983 | 51.8 |
- Called up share capital
| Shares in issue | £’000 | ||||
| 30 September 2023 | 176,968,887 | 1,770 | |||
| 30 September 2022 | 179,899,225 | 1,799 | |||
| 31 March 2023 | 177,441,775 | 1,774 |
- Reserves
The Special reserve is available to the Company to enable the purchase of its own shares in the market without affecting its ability to pay dividends/capital distributions.
| 30 Sep 2023 | 30 Sep 2022 | 31 Mar 2023 | |||
| £’000 | £’000 | £’000 | |||
| Capital redemption reserve | 71 | 1,711 | 32 | ||
| Share premium account | 2,252 | 81,236 | 428 | ||
| Funds held in respect of shares not yet allotted | - | 16 | - | ||
| Special reserve | 85,122 | 15,873 | 88,813 | ||
| Capital reserve realised | (5,627) | - | - | ||
| Revaluation reserve | 3,619 | 6,024 | 2,592 | ||
| Revenue reserve | (1,440) | (880) | (1,656) | ||
| Total reserves | 83,997 | 103,980 | 90,209 |
Distributable reserves are calculated as follows:
| 30 Sep 2023 | 30 Sep 2022 | 31 Mar 2023 | |||
| £’000 | £’000 | £’000 | |||
| Special reserve | 85,122 | 15,873 | 88,813 | ||
| Capital reserve | (5,627) | - | - | ||
| Revenue reserve | (1,440) | (880) | (1,656) | ||
| Unrealised losses (excluding unrealised unquoted gains) | (12,622) | (11,434) | (9,973) | ||
| 65,433 | 3,559 | 77,184 |
- Investments
| Unquoted investments | Quoted on Aquis Growth Market | Quoted on Main Market | Quoted on AIM | Total | |
| £'000 | £'000 | £'000 | £'000 | £'000 | |
| Opening cost at 1 April 2023 | 60,855 | 48 | 7,216 | 16,074 | 84,193 |
| Unrealised gains/(losses) at 1 April 2023 | 6,195 | (47) | (2,056) | (1,500) | 2,592 |
| Permanent impairment losses at 1 April 2023 | (15,288) | - | - | (270) | (15,558) |
| Opening fair value at 1 April 2023 | 51,762 | 1 | 5,160 | 14,304 | 71,227 |
| Movements in the year: | |||||
| Purchased at cost | 1,900 | 300 | - | 159 | 2,359 |
| Disposals - proceeds | (2,208) | - | - | (1,087) | (3,295) |
| - realised (losses)/gains on disposals* | (6,211) | - | - | 590 | (5,621) |
| Unrealised foreign exchange gains | 110 | - | - | - | 110 |
| Unrealised gains/(losses)* | 3,590 | (94) | (391) | (2,014) | 1,091 |
| Closing value at 30 Sept 2023 | 48,943 | 207 | 4,769 | 11,952 | 65,871 |
| Closing cost at 30 Sept 2023 | 54,336 | 348 | 7,216 | 15,736 | 77,636 |
*Losses on investments in the Income Statement include realised gains relating to the deferred consideration receipts totalling £419,000 from ADC Biotechnology Limited (£310,000), StorageOS Inc (£89,000) and Black & White Hospitality Limited (£20,000).
* Losses on investments in the Income Statement also include unrealised gains which are a result of the deferred consideration debtor decrease of £174,000. The debtor movement reflects the recognition of amounts receivable in respect of DIA Imaging Analysis Limited (£47,000) and Imagen Limited (£156,000), offset by receipts in respect of ADC Biotechnology Limited (£310,000) and StorageOS Inc (£89,000) and FX uplifts made against balances in respect of Efundamentals Group Limited (£5,000) and StorageOS Inc (£17,000).
The fair value of investments is determined using the detailed accounting policy as shown in the audited financial statements for the year ended 31 March 2023. The Company has categorised its financial instruments using the fair value hierarchy as follows:
Level 1 Reflects financial instruments quoted in an active market (quoted companies and fixed interest bonds);
Level 2 Reflects financial instruments that have prices that are observable either directly or indirectly; and
Level 3 Reflects financial instruments that use valuation techniques that are not based on observable market data (investments in unquoted shares and loan note investments).
| Level 1 | Level 2 | Level 3 | 30 Sep 2023 | Level 1 | Level 2 | Level 3 | 31 Mar 2023 | |
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
| Quoted on AIM | 11,952 | - | - | 11,952 | 14,304 | - | - | 14,304 |
| Quoted on Aquis | 207 | - | - | 207 | 1 | - | - | 1 |
| Quoted on main market | 4,769 | - | - | 4,769 | 5,160 | - | - | 5,160 |
| Unquoted loan notes | - | - | 10,467 | 10,467 | - | - | 10,467 | 10,467 |
| Unquoted equity | - | - | 38,476 | 38,476 | - | - | 41,295 | 41,295 |
| 16,928 | - | 48,943 | 65,871 | 19,465 | - | 51,762 | 71,227 |
The unaudited financial statements set out herein do not constitute statutory accounts within the meaning of Section 434 of the Companies Act 2006 and have not been delivered to the Registrar of Companies. The figures for the year ended 31 March 2023 have been extracted from the financial statements for that year, which have been delivered to the Registrar of Companies; the Auditor’s report on those financial statements was unqualified.
11. Going concern
The Directors have reviewed the Company’s financial resources at the period end and concluded that the Company is well placed to manage its business risks.
The Directors confirm that they are satisfied that the Company has adequate resources to continue to operate for the foreseeable future. For this reason, the Directors believe that the Company continues to be a going concern and that it is appropriate to apply the going concern basis in preparing the financial statements.
12. Risks and uncertainties
Under the Disclosure and Transparency Rules, the Board is required, in the Company’s half-year results, to report on principal risks and uncertainties facing the Company over the remainder of the financial year. The lingering impact of the coronavirus pandemic and the consequential behavioural changes still creates uncertainty for some businesses but has not changed the nature of these risks.
The Board has concluded that the key risks are:
(i) compliance risk of failure to maintain approval as a VCT; and
(ii) investment risk associated with investing in small and immature businesses.
The Company’s compliance with the VCT regulations is continually monitored by the Investment Adviser, who regularly reports to the Board on the current position. The Company also retains Philip Hare & Associates LLP to provide regular reviews and advice in this area.
In order to make VCT qualifying investments, the Company has to invest in small businesses which are often immature. The impact of the coronavirus pandemic has been significant on some portfolio companies and, in many cases, the VCT regulations restrict the Company from making further investment into these businesses, so the Investment Adviser seeks to provide whatever other support they can to these businesses, including encouraging them to take advantage of Government support that may be available. The Company also has a limited period in which it must invest the majority of its funds into VCT qualifying investments. The Investment Adviser follows a rigorous process in vetting and careful structuring of new investments, including taking a charge over the assets of the business wherever possible and, after an investment is made, closely monitoring the business.
Increasing inflation, particularly on wages and other costs has developed into an emerging risk during the period. The Investment Adviser’s close relationship with the investee companies allow it to ensure that the businesses properly assess the potential impact of increasing costs and the extent to which these may or may not be able to be passed on to the end customer.
The Board is satisfied that these approaches provide satisfactory management of the key risks.
13. Contingent liability
As outlined in the Chairman’s Statement on page 2, since September 2020, the Company has used IBP Markets Limited ("IBP") as custodian for its quoted investments. IBP is an FCA authorised and regulated wholesale broker, providing custody services and access to equity and fixed income securities for non-retail clients (which includes the Company). On 13 October 2023, the FCA published a supervisory notice under section 55L(3)(a) of the Financial Services and Markets Act 2000, imposing certain restrictions on IBP. On the same date, IBP applied to the High Court and special administrators were appointed. The special administrators have yet to publish an estimated outcome statement and therefore the full impact is currently unknown. The Investment Adviser is actively collaborating with the special administrators to reach a resolution and will communicate with Shareholders when further information becomes available.
The Investment Adviser is in regular dialogue with the special administrators. The outcome remains subject to change particularly as additional claims may be made on custody assets and client money and there remains a risk to the positions. However, considering the information made available to the Company at the date of this report, there is currently little indication that there will be a materially adverse impact to Shareholders with respect to the custody assets. The position with respect to client money remains to be determined, but total cash at IBP represented less than 1.5% of NAV as at 30 September.
14. The Directors confirm that, to the best of their knowledge, the half yearly financial report has been prepared in accordance with the “Statement: Half-Yearly Financial Reports” issued by the UK Accounting Standards Board as well as in accordance with FRS 104 Interim Financial Reporting and the half-yearly financial report includes a fair review of the information required by:
(a) DTR 4.2.7R of the Disclosure and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements, and a description of the principal risks and uncertainties for the remaining six months of the year; and
(b) DTR 4.2.8R of the Disclosure and Transparency Rules, being related party transactions that have taken place during the first six months of the current financial year and that have materially affected the financial position or performance of the entity during that period, and any changes in the related party transactions described in the last annual report that could do so.
15. Copies of the unaudited half-yearly financial results will be sent to Shareholders shortly. Further copies can be obtained from the Company’s Registered Office and will be available for download from
www.foresightgroup.eu/products/thames-ventures-vct-1-plc
End
